Company intelligence / Profile preview
ILiAD Biotechnologies
Weston, Florida, United Statesiliadbio.com ↗
- Ownership
- Private
- Employees
- ~16
- Development stage
- Phase 2
01
Overview
BPZE1 has demonstrated safety, robust mucosal/systemic immune responses, and protection against B. pertussis colonization in four Phase II clinical trials involving adults and school-age children. It showed a significant reduction of nasopharyngeal colonization versus controls in non-human primate studies. The vaccine also demonstrated stability (>2 years at refrigerated temperatures) suitable for global distribution.
- Therapeutic areas
- ImmunologyNeurologyInfectious Diseases
- Modalities
- Live attenuated vaccinesVector-based vaccines (B-Tech™ platform)
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
Request access →03
Partnerships
Licensed BPZE1 technology from Institut Pasteur de Lille & INSERMLetter of intent with hVIVO to conduct pivotal Phase III trial
Beyond the preview
Go deeper on ILiAD Biotechnologies.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ILiAD Biotechnologies.